treatment faculty group 504-c
Page preview (5 pages)
Scroll down 👇
About "treatment faculty group 504-c"
powerpoint presentation treatment faculty group 504-c by temirov farkhod secondary headaches disclosures reference arial 10pt left aligned footer arial 10pt right aligned 2 allergan: advisory board, research support, speaker’s panel amgen: advisory board promius pharma: advisory board supernus: advisory board teva: advisory board eli lilly: advisory board, research support curelator: consultant paid in options 1. to recognize “red flags” for headaches with a discernable cause is it time to rename “secondary headaches”? 2. to reinforce understanding on how to diagnose, manage and treat dangerous and rapidly progressive headaches due to specific causes. 3. to review headaches that we may not encounter on a regular basis. how much of our practice is primary headache disorders due to access re...
This file contains 53 pages in PPTX format (7.4 MB). To download "treatment faculty group 504-c", click the Telegram button on the left.